RANKINGS

Key list: leading biopharma companies in Europe by revenue

Powered by 

This month our pharma industry key list brings you the 15 leading biopharma companies in Europe by revenue, as ranked by GlobalData's Pharma Intelligence Centre. All numbers up to date as of April 2021.

Company name

Headquarters location  

No. of employeesRevenue ($M)

F. Hoffmann-La Roche Ltd

Switzerland

101,46561,874

Bayer AG

Germany99,53848,752

Novartis AG

Switzerland105,79448,624

GlaxoSmithKline Plc

UK94,06643,081

Sanofi

France99,41242,129

Fresenius SE & Co KGaA

Germany299,59439,643

AstraZeneca Plc

UK76,10024,384

Boehringer Ingelheim International GmbH

Germany50,00021,268

Novo Nordisk AS

Denmark44,72318,299

Merck KGaA

Germany58,09618,083

Grifols SA

Spain23,6685,708

UCB SA

Belgium8,4095,500

Recordati SpA

Italy4,3231,659

Horizon Therapeutics Plc

Ireland1,3951,300

Genmab AS

Denmark781805
Go to article: Home | Antibiotic AdjacentGo to article: In this issueGo to article: ContentsGo to article: SHL Company InsightGo to article: SHL MedicalGo to article: TiveGo to article: Controlant Company InsightGo to article: ControlantGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: L.B. Bohle MaschinenGo to article: L.B Bohle Company InsightGo to article: ACG WorldwideGo to article: CommentGo to article: HPV infections drop due to widespread vaccinationGo to article: Europe reports the highest prevalence of chronic cough across the 7MMGo to article: How could vaccine hesitancy affect the prevalence of hearing disorders?Go to article: Datwyler Company Insight Go to article: DatwylerGo to article: RegPakGo to article: PfeifferGo to article: In DepthGo to article: Antibiotic adjacent: the alternatives tackling AMR Go to article: Regenerative medicine: ready for the big leagues? Go to article: Human challenge trials: pandemic exit strategy or ethical nightmare?Go to article: Drug dispensing goes digitalGo to article: Could this Novartis initiative finally cure sickle cell disease?Go to article: Centessa Pharmaceuticals: forging a new path for pharma R&DGo to article: Biomax Company InsightGo to article: BiomaxGo to article: DuojectGo to article: Duoject Company InsightGo to article: In DataGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: The Solubility Company - Company Insight Go to article: The Solubility companyGo to article: MyonexGo to article: BaxterGo to article: EventsGo to article: Next issue